Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes

Lian Engelen, Soren S. Lund, Isabel Ferreira, Lise Tarnow, Hans-Henrik Parving, Jorgen Gram, Kaj Winther, Oluf Pedersen, Tom Teerlink, Rob Barto, Coen D. A. Stehouwer, Allan A. Vaag, Casper G. Schalkwijk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)371-379
JournalEuropean Journal of Endocrinology
Volume164
Issue number3
DOIs
Publication statusPublished - Mar 2011

Cite this